Search

Displaying results 3301 - 3310 of 10000 in total
  1. Drug

    Fimepinostat

    go.drugbank.com/drugs/DB11891
    Investigational

    Fimepinostat (CUDC-907) has been used in trials studying the treatment of lymphoma, solid tumors, breast cancer, multiple myeloma, and NUT midline carcinoma, among others.

    Synonyms: 5-pyrimidinecarboxamide, N-hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]-, N-hydroxy-2-(((2-(6-methoxypyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxamideCategories: Heterocyclic Compounds, 1-Ring, Phosphatidylinositol 3-Kinases, antagonists & inhibitors
  2. Drug

    Efatutazone

    go.drugbank.com/drugs/DB11894
    Investigational

    Efatutazone has been used in trials studying the treatment of Lymphoma, Liposarcoma, Solid Tumors, Multiple Myeloma, and Recurrent Thyroid Cancer, among others.

    Categories: Heterocyclic Compounds, 1-Ring
  3. Drug

    2,4-thiazolidinedione

    go.drugbank.com/drugs/DB11898
    Investigational

    Thiazolidinedione has been investigated for the treatment of Type 2 Diabetes, Diabetes Mellitus, and DIABETES MELLITUS, TYPE 2.

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Timapiprant

    go.drugbank.com/drugs/DB11900
    Investigational

    OC000459 is under investigation for the treatment of Severe Eosinophilic Asthma. OC000459 has been investigated for the treatment of Bronchial Asthma.

    Categories: Heterocyclic Compounds, 2-Ring
  5. Drug

    Rociletinib

    go.drugbank.com/drugs/DB11907
    Investigational

    Rociletinib has been used in trials studying the treatment and prevention of Nonsmall Cell Lung Cancer, Non-small Cell Lung Cancer, and Locally Advanced or Metastatic Non-small Cell Lung Cancer.

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Lebrikizumab

    go.drugbank.com/drugs/DB11914
    ApprovedInvestigational

    This approval is based on the positive results obtained from the Phase 3 studies ADvocate 1 and ADvocate 2, where nearly 80% of patients taking lebrikizumab either as monotherapy or combination therapy … Lebrikizumab is a monoclonal antibody that binds to IL-13 with high affinity and slow off-rate.[L51374] It binds to a different epitope compared [tralokinumab].

  7. Drug

    Indium In-111

    go.drugbank.com/drugs/DB11916
    Investigational

    Indium In-111 is under investigation in clinical trial NCT00493454 (Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas).

  8. Drug

    Guadecitabine

    go.drugbank.com/drugs/DB11918
    Investigational

    Guadecitabine is under investigation for the treatment of Previously Treated Metastatic Colorectal Cancer.

    Categories: Heterocyclic Compounds, 1-Ring
  9. Drug

    6-O-benzylguanine

    go.drugbank.com/drugs/DB11919
    Investigational

    6-O-benzylguanine has been used in trials studying the treatment of HIV Infection, Adult Gliosarcoma, Adult Glioblastoma, Stage I Adult Hodgkin Lymphoma, and Stage II Adult Hodgkin Lymphoma, among others

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesSynonyms: O(6)-Benzylguanine
  10. Drug

    Lesogaberan

    go.drugbank.com/drugs/DB11920
    Investigational

    Lesogaberan has been used in trials studying the treatment and basic science of GERD, Reflux, Heartburn, Regurgitation, and Reflux Disease, among others.

    Categories: GABA-A Receptor Agonists